Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

In the News

WebMD: 150-Year-Old Drug May Help Parkinson's Patients Friday, April 21, 2017

A new trial suggests that the injectable drug apomorphine (Apokyn) can significantly shorten “off” times between levodopa dosages. Parkinson’s Foundation National Medical Director Dr. Michael S. Okun is quoted.

Miami Herald: Foundation envisions a world without Parkinson’s disease Monday, April 17, 2017

Parkinson Foundation CEO John L. Lehr gives discusses a world without Parkinson's and how he intends to bring his vision to fruition to better the lives of those affected by Parkinson's.

Niagara Gazette: GUEST VIEW: April Is A Time for Parkinson’s Awareness Thursday, April 13, 2017

NPF division’s Western New York chapter is celebrating Parkinson’s Awareness Month through distributing blue light bulbs, sponsoring wear blue day and hosting its annual wine tasting.

PR Newswire: Playing Golf Alleviates Symptoms for Chicago Man with Parkinson's Disease Tuesday, April 11, 2017

When Gary Smith was diagnosed with PD he began playing golfing at Topgolf®. He noticed that his stiffness lessened and his health improved. In honor of Gary and World Parkinson's Day, Topgolf donated $10,000 to the Parkinson's Foundation.

The Lancet United States of Health Blog: Raising awareness to end Parkinson’s Tuesday, April 11, 2017

John L. Lehr, CEO of the Parkinson's Foundation, and Allison Willis, M.D., M.S., a Parkinson’s disease specialist and assistant professor of neurology and biostatistics in epidemiology at the University of Pennsylvania, about a new initiative to close the gap in sex-based disparities.

Abbvie: Uniting for Parkinson's on the 200th Anniversary of the Disease Friday, April 7, 2017

Leading PD non-profits share their Awareness Month plans and what they want others to know about Parkinson’s. Leilani Pearl, the Foundation’s vice president of marketing and communications, is quoted.

NPR: FDA Approves Marketing Of Consumer Genetic Tests For Some Conditions Friday, April 7, 2017

Parkinson’s Foundation CEO John Lehr is quoted in regards to the FDA’s recent approval to allow 23andMe to market genetic health risk tests.

New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers Thursday, April 6, 2017

For the first time, the FDA is allowing a company to sell genetic tests for disease risk directly to consumers. The test will provide the likelihood that people could develop conditions like Parkinson’s. Jim Beck, Parkinson’s Foundation chief scientific officer is quoted.

MedCity News: FDA Allows 23andme To Reintroduce 10 Genetic Health Risk Reports For Parkinson’s, Alzheimer’s, And More Thursday, April 6, 2017

23andMe announced it’s recent FDA authorization to market its Personal Genome Service Genetic Health Risk (GHR) tests for 10 hereditary disorders. Parkinson’s Foundation CEO John Lehr is quoted.

NASDAQ: Parkinson’s Foundation to Ring The Nasdaq Stock Market Opening Bell Wednesday, April 5, 2017

Parkinson’s Foundation CEO John Lehr rang the opening bell in honor of Parkinson’s Awareness Month along with Vice Chair Howard Morgan, board members and staff.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.